Skip to main content

Table 2 Basic demographic, laboratory and operative data statistics of study cohort for categorical variables

From: Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397)

 

Count (N)

N (%)

Gender (Male)

105

70,9%

Hiperlipidemia

103

69,6%

Hipertension

123

83,1%

Diabetes mellitus

45

30,4%

Smoking habit

30

20,3%

Beta blockers

113

76,4%

Amiodarone

16

10,8%

Antiplatelet therapy

104

70,3%

Lipid lowering drugs

107

72,3%

Procedure type

Isolated CABG

84

56,8%

Valve procedure

34

23,0%

Combined procedure

18

12,2%

Other

12

8,1%

Transfused

116

78,4%

Transfused fresh frozen plasma

30

20,3%

Transfused packed red blood cells

119

80,4%

Transfused Fibrinogen concentrate

11

7,4%

Transfused Platelet Concentrate

6

4,1%